Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Novel CCR5 antagonist profiled at Novartis

March 27, 2008

Rilonacept available in U.S. for cryopyrin-associated periodic syndromes

March 26, 2008

IgG-hydrolyzing enzyme shows promise against autoimmune diseases

March 26, 2008

Privigen pharmacokinetics and high infusion rate tolerability studied

March 26, 2008

Mepolizumab investigated in eosinophilic esophagitis and nasal polyposis

March 25, 2008

Novel Fc receptor peptide antagonist effectively reduces IgG levels in monkeys

March 20, 2008

Sustained rilonacept effects seen in cryopyrin-associated periodic syndromes

March 20, 2008

Astellas receives approvable letter for NDA for once-daily tacrolimus in kidney transplants

March 19, 2008

FDA licenses sanofi-aventis' Daptacel as fifth consecutive DTaP vaccine dose for children

March 18, 2008

Recent Kyorin patent describes new treatment option for transplant rejection

March 14, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...